CYP-LAD
CYP-LAD, also known as 6-cyclopropyl-6-nor-lysergic acid diethylamide or as TRALA-22, is a lysergamide and analogue of lysergic acid diethylamide (LSD).
≈ 1 min read
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
CYP-LAD, also known as 6-cyclopropyl-6-nor-lysergic acid diethylamide or as TRALA-22, is a lysergamide and analogue of lysergic acid diethylamide (LSD). It was patented by Daniel Trachsel and colleagues in 2023 as an LSD analogue with modified LSD-like action, and had also previously been claimed in a 2022 patent by Gilgamesh Pharmaceuticals.
See also
Substituted lysergamide CPM-LAD
External links
CYP-LAD - Isomer Design
Text derived from https://en.wikipedia.org/w/index.php?oldid=1368387732 under CC BY-SA 4.0; modifications have been made.